Vor Biopharma Inc. (VOR) stock
VORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$18.18−0.79 (-4.16%)
Close on Nov 17, 2026Market cap $1.12BP/E –Yield –
Vor Biopharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Vor Biopharma's price to book ratio was 3.9× on Jul 31, 2025, against 0.5× a year earlier. Over the last 4 years it ranged from 0.4× to 3.9×, with a median of 1.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jul 31, 2025 | 3.9× | +2.9 |
| 2024 | Dec 31, 2024 | 1.0× | +0.2 |
| 2023 | Dec 29, 2023 | 0.9× | −0.7 |
| 2022 | Dec 30, 2022 | 1.6× | −0.2 |
| 2021 | Dec 31, 2021 | 1.8× | – |
See a number that looks wrong?